Neuronetics, Inc.STIMNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 55 | 65 | 71 |
| Gross Profit | 44 | 50 | 52 |
| Operating Income | -28 | -35 | -31 |
| Net Income | -31 | -37 | -30 |
| EBITDA | -27 | -32 | -23 |
| EPS Diluted | -1.22 | -1.38 | -1.05 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 94 | 70 | 60 |
| Total Current Assets | 115 | 99 | 94 |
| Total Assets | 141 | 117 | 116 |
| Total Current Liabilities | 16 | 33 | 20 |
| Total Liabilities | 56 | 60 | 82 |
| Total Equity | 85 | 57 | 34 |
| Total Debt | 40 | 40 | 62 |
| Net Debt | -55 | -31 | 3 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -28 | -31 | -32 |
| Capital Expenditure | -2 | -3 | -2 |
| Free Cash Flow | -30 | -34 | -34 |
| Stock-Based Comp | 8 | 9 | 7 |
| Net Change in Cash | 45 | -24 | -11 |